Lista de obras -

"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients

artículo científico publicado en 2019

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

artículo científico publicado en 2006

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma

artículo científico publicado en 2010

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

artículo científico publicado en 2010

Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection

artículo científico publicado en 2011

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

scientific article published on 01 September 2019

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes

scientific article published on 14 June 2018

Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectin

artículo científico publicado en 2020

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model

artículo científico publicado en 2022

CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells

artículo científico publicado en 2022

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

artículo científico publicado en 2011

Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours

artículo científico publicado en 2020

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

artículo científico publicado en 2020

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

artículo científico publicado en 2008

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

artículo científico publicado en 2006

Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity

artículo científico publicado en 2014

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

artículo científico publicado en 2007

Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.

artículo científico publicado en 2018

Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma

artículo científico publicado en 2011

Data from CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity

Design and development of therapies using chimeric antigen receptor-expressing T cells

artículo científico publicado en 2014

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

artículo científico publicado en 2018

Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors

scientific article published on 01 March 2019

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

artículo científico publicado en 2008

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy

artículo científico publicado en 2018

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

artículo científico publicado en 2011

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

artículo científico publicado en 2012

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors

artículo científico publicado en 2019

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

artículo científico publicado en 2017

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

artículo científico publicado en 2018

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

artículo científico publicado en 2015

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation

artículo científico publicado en 2012

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution

scientific article published on 18 November 2019

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation

artículo científico publicado en 2006

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

artículo científico publicado en 2003

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

scientific article published on 01 April 2019

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

scientific article published on 16 January 2019

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

artículo científico publicado en 2017

Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

artículo científico publicado en 2017

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

artículo científico publicado en 2015

Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment

scientific article published on 22 February 2019

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

artículo científico publicado en 2012

Redirecting T cells to hematological malignancies with bispecific antibodies.

artículo científico publicado en 2017

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

artículo científico publicado en 2007

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

artículo científico publicado en 2013

Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma

scientific article published on 14 October 2018

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

artículo científico publicado en 2008

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

artículo científico publicado en 2013

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

artículo científico publicado en 2010

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

artículo científico publicado en 2004

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)

artículo científico publicado en 2006

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

scientific article published on 15 July 2020

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma

artículo científico publicado en 2018

Lista de obras de

"Mini" bank of only 8 donors supplies CMV-directed T cells to diverse recipients

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Administration of latent membrane protein 2-specific cytotoxic T lymphocytes to patients with relapsed Epstein-Barr virus-positive lymphoma

Adoptive transfer of EBV-specific T cells results in sustained clinical responses in patients with locoregional nasopharyngeal carcinoma

Adverse events following infusion of T cells for adoptive immunotherapy: a 10-year experience

Aggressive peripheral CD70-positive T-cell lymphoma associated with severe chronic active EBV infection

Allogeneic hematopoietic stem cell transplant for relapsed and refractory non-Hodgkin lymphoma in pediatric patients

Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered Lymphocytes

Antitumor effects of CAR T cells redirected to the EDB splice variant of fibronectin

B7-H3 Specific CAR T Cells for the Naturally Occurring, Spontaneous Canine Sarcoma Model

CAR T cells redirected to cell surface GRP78 display robust anti-acute myeloid leukemia activity and do not target hematopoietic progenitor cells

Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States

Chimeric Antigen Receptor-modified T cells targeting EphA2 for the immunotherapy of paediatric bone tumours

Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS post-allogeneic transplant

Comparable outcome of alternative donor and matched sibling donor hematopoietic stem cell transplant for children with acute lymphoblastic leukemia in first or second remission using alemtuzumab in a myeloablative conditioning regimen

Comparable outcomes of matched-related and alternative donor stem cell transplantation for pediatric severe aplastic anemia

Complementation of antigen-presenting cells to generate T lymphocytes with broad target specificity

Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Current Allogeneic Hematopoietic Stem Cell Transplantation for Pediatric Acute Lymphocytic Leukemia: Success, Failure and Future Perspectives-A Single-Center Experience, 2008 to 2016.

Cytotoxic T lymphocytes simultaneously targeting multiple tumor-associated antigens to treat EBV negative lymphoma

Data from CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity

Design and development of therapies using chimeric antigen receptor-expressing T cells

EBV/LMP-specific T cells maintain remissions of T- and B-cell EBV lymphomas after allogeneic bone marrow transplantation

Engineering for Success: Approaches to Improve Chimeric Antigen Receptor T Cell Therapy for Solid Tumors

Enhancing the in vivo expansion of adoptively transferred EBV-specific CTL with lymphodepleting CD45 monoclonal antibodies in NPC patients

Epstein-Barr Virus (EBV)-derived BARF1 encodes CD4- and CD8-restricted epitopes as targets for T-cell immunotherapy

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein-Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma

Genetic Modification Strategies to Enhance CAR T Cell Persistence for Patients With Solid Tumors

HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

High Incidence of Autoimmune Disease after Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease

Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Immunotherapeutic strategies to prevent and treat human herpesvirus 6 reactivation after allogeneic stem cell transplantation

Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution

In vivo expansion of LMP 1- and 2-specific T-cells in a patient who received donor-derived EBV-specific T-cells after allogeneic stem cell transplantation

Large-scale expansion of dendritic cell-primed polyclonal human cytotoxic T-lymphocyte lines using lymphoblastoid cell lines for adoptive immunotherapy

Lentiviral Gene Therapy Combined with Low-Dose Busulfan in Infants with SCID-X1

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome

Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies

Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment

Rapidly generated multivirus-specific cytotoxic T lymphocytes for the prophylaxis and treatment of viral infections

Redirecting T cells to hematological malignancies with bispecific antibodies.

Regression of experimental medulloblastoma following transfer of HER2-specific T cells

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma

Successful treatment of stem cell graft failure in pediatric patients using a submyeloablative regimen of campath-1H and fludarabine

Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins

The costs and cost-effectiveness of allogeneic peripheral blood stem cell transplantation versus bone marrow transplantation in pediatric patients with acute leukemia

The generation and characterization of LMP2-specific CTLs for use as adoptive transfer from patients with relapsed EBV-positive Hodgkin disease

Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Tumor-Specific T-Cells Engineered to Overcome Tumor Immune Evasion Induce Clinical Responses in Patients With Relapsed Hodgkin Lymphoma